Caraka Clinical and Translational Sciences Private Limited
About Caraka Clinical and Translational Sciences Private Limited
Data last updated:
Caraka Clinical and Translational Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the research and development sector. It was incorporated on 23 April 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74220TG2012PTC080473.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Caraka Clinical and Transational Sciences Private Limited. It is led by directors Jyothsna Tirunagari and Muddala Srinivas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H – No. 9 – 133 Plot No 367 Laxmi Nagar Colony 7th Cross Boduppal., Hyderabad, Telangana, India – 500039.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.63 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net loss of ₹1,720 (net margin -1.1%) and EBITDA of ₹5,910 (EBITDA margin 3.6%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 26% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH – No. 9 – 133 Plot No 367 Laxmi Nagar Colony 7th Cross Boduppal., Hyderabad, Telangana, India – 500039
- IndustryResearch & Development, Research & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Caraka Clinical and Translational Sciences Private Limited
The main business activity of Caraka Clinical and Translational Sciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Caraka Clinical and Translational Sciences Private Limited FY 2025 filings available
Caraka Clinical and Translational Sciences Private Limited reported revenue of ₹1.63 Lakh (down 29% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Caraka Clinical and Translational Sciences Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 26% over five years, including a 29% fall in the latest year. EBITDA rose 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Caraka Clinical and Translational Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5,910 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1,720 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Caraka Clinical and Translational Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -1.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Caraka Clinical and Translational Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Caraka Clinical and Translational Sciences Private Limited
Caraka Clinical and Translational Sciences Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Scientific research and development). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Institute of Education and Research | ₹1.69 Lakh (FY 2024) | •••• | •••• | 44.0% | •••• | Noida, Uttar Pradesh, India |
| Vision Institute of Scientific Education and Research India Private Limited | ₹1.69 Lakh (FY 2021) | •••• | •••• | -98.0% | •••• | Secunderabad, Telangana, India |
| Hants Laboratories Private Limited | ₹1.65 Lakh (FY 2024) | •••• | •••• | •••• | North East, Delhi, India | |
| Allele Life Sciences Private Limited. | ₹1.65 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | New Delhi, Delhi, India |
| Adoks Pharmaceuticals Private Limited | ₹1.64 Lakh (FY 2016) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Caraka Clinical and Translational Sciences Private Limited this company | ₹1.63 Lakh (FY 2024) | •••• | •••• | -29.0% | •••• | Hyderabad, Telangana, India |
| Trans Vitals Private Limited | ₹1.62 Lakh (FY 2025) | •••• | •••• | -87.0% | •••• | Pune, Maharashtra, India |
| NFS Engineering Private Limited | ₹1.62 Lakh (FY 2024) | •••• | •••• | -88.0% | •••• | Ranchi, Jharkhand, India |
| Suryashakti Bizadvize Private Limited | ₹1.61 Lakh (FY 2025) | •••• | •••• | -99.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Vasishth Genomics Research Lab Private Limited | ₹1.61 Lakh (FY 2025) | •••• | •••• | -63.0% | •••• | Bangalore, Karnataka, India |
| C.G.S. 4D Civil Engineering Services (OPC) Private Limited | ₹1.6 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Kanpur, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Caraka Clinical and Translational Sciences by revenue in the same principal business activity (Scientific research and development), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Caraka Clinical and Translational Sciences Private Limited
Caraka Clinical and Translational Sciences Private Limited is audited by MUKESH R SHARMA & CO. for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MUKESH R SHARMA & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Caraka Clinical and Translational Sciences Private Limited
Caraka Clinical and Translational Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Muddala Srinivas | Additional Director | 03 Oct 2018 | 8 Years 0 Months | Current |
| Jyothsna Tirunagari | Director | 17 Jul 2013 | 13 Years 2 Months | Current |
Ownership and Shareholding of Caraka Clinical and Translational Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Caraka Clinical and Translational Sciences Private Limited
Caraka Clinical and Translational Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Caraka Clinical and Translational Sciences Private Limited
Employment history and EPFO contributions of people linked to Caraka Clinical and Translational Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Caraka Clinical and Translational Sciences Private Limited
Caraka Clinical and Translational Sciences has one previous CIN (Corporate Identification Number): U74220AP2012PTC080473. The current CIN is U74220TG2012PTC080473, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74220TG2012PTC080473 | Current |
| U74220AP2012PTC080473 | Previous |
Recent Activity on Caraka Clinical and Translational Sciences Private Limited
Caraka Clinical and Translational Sciences Private Limited has 4 board changes on record since 2013: 2 appointments and 2 cessations. The latest: Jagadeeswara Madineni Naidu ceased to be Director on 03 Oct 2018.
Credit Ratings, Litigation & Regulatory Alerts for Caraka Clinical and Translational Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Caraka Clinical and Translational Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Caraka Clinical and Translational Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Caraka Clinical and Translational Sciences Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Caraka Clinical and Translational Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Caraka Clinical and Translational Sciences Private Limited
Caraka Clinical and Translational Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in the research and development industry. It was incorporated on 23 April 2012 (14+ years old) and is registered under CIN U74220TG2012PTC080473.
Caraka Clinical and Translational Sciences reported revenue of ₹1.63 Lakh for FY 2024 (down 29% YoY).
Caraka Clinical and Translational Sciences has 2 current directors:
- Muddala Srinivas - Additional Director
- Jyothsna Tirunagari - Director
Caraka Clinical and Translational Sciences reported a net loss of ₹1,720 (net margin -1.1%) and EBITDA of ₹5,910 (EBITDA margin 3.6%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Caraka Clinical and Translational Sciences is -9% over three years and -26% over five years. In the latest year (FY 2024) revenue fell 29%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Caraka Clinical and Translational Sciences is U74220TG2012PTC080473. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Caraka Clinical and Translational Sciences was incorporated on 23 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Caraka Clinical and Translational Sciences by revenue are Institute of Education and Research, Vision Institute of Scientific Education and Research India Private Limited, Hants Laboratories Private Limited, Allele Life Sciences Private Limited, Adoks Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Scientific research and development).
Jagadeeswara Madineni Naidu ceased to be Director on 03 Oct 2018. Muddala Srinivas was appointed as Additional Director on 03 Oct 2018. Jyothsna Tirunagari was appointed as Director on 17 Jul 2013. Caraka Clinical and Translational Sciences has 4 board changes on record in total.
The registered office of Caraka Clinical and Translational Sciences is at H – No. 9 – 133 Plot No 367 Laxmi Nagar Colony 7th Cross Boduppal., Hyderabad, Telangana, India – 500039.
Caraka Clinical and Translational Sciences has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.